ArticleClinical Outcomes for Patients with Acute Myeloid Leukemia Harboring IDH1 Mutation After Intensive Chemotherapy
ArticleClinical Outcomes for Patients with Acute Myeloid Leukemia Harboring IDH1 Mutation After Intensive Chemotherapy
ArticleDNA Hypomethylating Agents as Maintenance Therapy for Acute Myeloid Leukemia in Elderly Patients: a Systematic Review
ArticleDNA Hypomethylating Agents as Maintenance Therapy for Acute Myeloid Leukemia in Elderly Patients: a Systematic Review
ArticleCORRELATION BETWEEN CD200 EXPRESSION ON LEUKEMIC STEM CELLS AND RESPONSE TO TREATMENT IN DE-NOVO ADULT ACUTE MYELOID LEUKEMIA PATIENTS
ArticleCORRELATION BETWEEN CD200 EXPRESSION ON LEUKEMIC STEM CELLS AND RESPONSE TO TREATMENT IN DE-NOVO ADULT ACUTE MYELOID LEUKEMIA PATIENTS
ArticleCD96 as a Leukemic Stem Cell Marker in Acute Myeloid Leukemia Patients: Relation to Remission Induction Chemotherapy
ArticleCD96 as a Leukemic Stem Cell Marker in Acute Myeloid Leukemia Patients: Relation to Remission Induction Chemotherapy
ArticlePROGNOSTIC IMPACT OF ISOCITRATE DEHYDROGENASE ENZYME ISOFORMS IDH1 & IDH2 MUTATIONS IN ACUTE MYELOID LEUKEMIA
ArticlePROGNOSTIC IMPACT OF ISOCITRATE DEHYDROGENASE ENZYME ISOFORMS IDH1 & IDH2 MUTATIONS IN ACUTE MYELOID LEUKEMIA
ArticleStudy on the Efficacy of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells in Induction of Acute Myeloid Leukaemia Blasts Maturation
ArticleStudy on the Efficacy of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells in Induction of Acute Myeloid Leukaemia Blasts Maturation
ArticleINTERLEUKIN 3 RECEPTOR (CD123) EXPRESSION IN ACUTE MYELOID LEUKAEMIA PATIENTS IN RELATION TO DISEASE CHARACTERISTICS AND TREATMENT OUTCOME
ArticleINTERLEUKIN 3 RECEPTOR (CD123) EXPRESSION IN ACUTE MYELOID LEUKAEMIA PATIENTS IN RELATION TO DISEASE CHARACTERISTICS AND TREATMENT OUTCOME